The R.I. Commerce Corp. has approved up to $9.2 million in incentives for Amgen Inc. to build a $165 million biomanufacturing plant in West Greenwich. The company expects to add 150 jobs to its existing 625 at its Rhode Island campus, with the potential to grow to up to 300, depending on business conditions and the performance at the facility. The company has facilities around the world, so it had to make a choice to expand in Rhode Island, one that it said was partially motivated by its historical success at the existing facility. The state estimates that over the 12 years covered by these incentives, it will receive $3.7 million in new net revenue.
Was the awarding of these incentives good public policy?